Compare LODE & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LODE | OSUR |
|---|---|---|
| Founded | 2008 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.1M | 174.3M |
| IPO Year | N/A | 1986 |
| Metric | LODE | OSUR |
|---|---|---|
| Price | $3.62 | $2.66 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $4.00 | $3.00 |
| AVG Volume (30 Days) | ★ 1.2M | 675.6K |
| Earning Date | 10-30-2025 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,778,445.00 | ★ $125,703,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,798.62 | $3.70 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 48.99 | N/A |
| 52 Week Low | $1.67 | $2.08 |
| 52 Week High | $6.13 | $4.22 |
| Indicator | LODE | OSUR |
|---|---|---|
| Relative Strength Index (RSI) | 48.55 | 62.78 |
| Support Level | $3.81 | $2.43 |
| Resistance Level | $4.10 | $2.50 |
| Average True Range (ATR) | 0.28 | 0.10 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 25.19 | 77.78 |
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.